Screening women with mammography provides a highly significant reduction in breast cancer-specific mortality, with the initial 30 percent mortality reduction among 40- to 74-year-old women invited to screening sustained over the long term, according to a study published in the July edition of Radiology. The researchers emphasized the need for long-term follow-up to accurately gauge the mortality benefits of screening. 

Although the use of postmastectomy radiation therapy (PMRT) increased among older women with high-risk breast cancer after the initial release of evidence-based guidelines, progress lagged between 1999 and 2005, suggesting the need for additional research to better bridge the gap between clinical evidence and practice, according to a study published in the July edition of Cancer.

Agfa HealthCare has teamed up with TeraRecon to combine the unified image and information management workflow of Agfa HealthCare's Impax 6 PACS with the advanced image processing of TeraRecon's iNtuition technology.

Stanford Hospitals and Clinics and Stanford University School of Medicine have opened the Stanford Womens Cancer Center, a new facility for women with breast or gynecologic cancers.

Boehringer Ingelheim and Eli Lilly have received a positive opinion from the European Medicines Agency's (EMA) medicinal committee recommending approval of linagliptin, 5 mg, film-coated tablets (to be marketed under the trade name Trajenta in Europe) for the treatment of adults with type 2 diabetes.

The Mayo Clinic will open a 13,000-square-foot radiation oncology treatment center in Northfield, Minn. on June 27.

GE Healthcare has received FDA clearance of its Optima XR220amx, Optima XR200amx and Brivo XR285amx, a new platform of mobile x-ray systems.

NorthStar Medical Radioisotopes has located a new 82,000 square-foot, $194 million production facility in Beloit, Wis., where the company hopes to create 150 jobs by 2016. The new facility will utilize linear accelerators to produce radioisotopes used for medical imaging.